These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 17971593)
1. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593 [TBL] [Abstract][Full Text] [Related]
2. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. Hanrahan EO; Valero V; Gonzalez-Angulo AM; Hortobagyi GN J Clin Oncol; 2006 May; 24(13):2113-22. PubMed ID: 16648513 [TBL] [Abstract][Full Text] [Related]
3. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
4. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
5. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176 [TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205 [TBL] [Abstract][Full Text] [Related]
7. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Rosenberg J; Chia YL; Plevritis S Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Chen SL; Hoehne FM; Giuliano AE Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916 [TBL] [Abstract][Full Text] [Related]
10. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264 [TBL] [Abstract][Full Text] [Related]
11. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617 [TBL] [Abstract][Full Text] [Related]
12. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy. Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O; Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568 [TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Patel S; Macdonald OK; Suntharalingam M Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and prognostic factors of patients with breast cancer: a retrospective review. Tantivatana T; Chongthanakorn M; Rongsriyam K; Katanyoo K J Med Assoc Thai; 2009 Aug; 92(8):1084-93. PubMed ID: 19694335 [TBL] [Abstract][Full Text] [Related]
16. Ratios of involved nodes in early breast cancer. Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850 [TBL] [Abstract][Full Text] [Related]
17. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. Swanson GM; Lin CS J Natl Cancer Inst Monogr; 1994; (16):69-77. PubMed ID: 7999472 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer. Owusu C; Lash TL; Silliman RA Breast J; 2007; 13(4):374-82. PubMed ID: 17593042 [TBL] [Abstract][Full Text] [Related]
19. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Macdonald OK; Lee CM; Tward JD; Chappel CD; Gaffney DK Cancer; 2006 Nov; 107(9):2127-33. PubMed ID: 16998937 [TBL] [Abstract][Full Text] [Related]
20. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Hill TD; Khamis HJ; Tyczynski JE; Berkel HJ Ann Epidemiol; 2005 Nov; 15(10):773-80. PubMed ID: 16257362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]